Stem Cell Therapeutics, Corp. (SSS) Corp. Sheet

Related News: Stem Cell Companies
Stem Cell Therapeutics, Corp. Articles - NTF Cells Significant Advantage in Pre-Clinical Study for Pa...
- Completion of Proof-of-Principle Studies Demonstrating Effic...
- Stroke Stem Cell Therapy Shows Promise...
- MultiCell Technologies Announced 10-KSB Filing and Science A...
- Cytori Therapeutics Posts Study on Adipose Stem Cells to Tre...
More Stem Cell Therapeutics, Corp. Articles

Corporate Summary (site quote):

Calgary-based Stem Cell Therapeutics Corp. (SCT) is a biotechnology company focused on the development of its technology platform and intellectual property to selectively induce a patient's own stem cells to proliferate in the brain.

SCT's core technology, which includes its lead therapeutic product NTx(TM)-265, has been demonstrated to increase the number of innate adult stem cells that grow in place when this therapeutic approach is applied to test animals

This fundamental technology will be further developed to create specific disease treatments for stroke, Huntington's disease, Alzheimer's disease and other neurodegenerative conditions.

Stem Cell Therapeutics, Corp. Contact InfoStem Cell Therapeutics, Corp.
Suite 1000, 1520 4th St SW
Calgary, AB, T2R 1H5, Canada
Telephone: 403.245.5495
Fax: 403.245.5411
E-mail: info@stemcellthera.com

Corporate Website - http://www.stemcellthera.com/
Stock Quote - TSX: SSS



Posted on January 21, 2005 02:21 PM

 
Stem Cell Research Site Map